CHONDROÏTINE-GLUCOSAMINE LPEV®
Food supplement declared in France, declaration No 2021-4-1201, decision dated 21 April 2021
CHONDROÏTINE-GLUCOSAMINE LPEV®, from LPEV, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Alpinia officinarum 50 mg per day, Sulfate de glucosamine, Sulfate de chondroïtine. None of the rules we check flags an issue with its declared composition.
- Brand
- not provided
- Food business operator placing the product on the market
- LPEV
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Tablet
- Daily dose
- 3 comprimés
- Directions for use
- 3 comprimés par jour à avaler avec un grand verre d'eau
- Not recommended (according to the manufacturer)
- Breastfeeding women, Children (under 12), Pregnant women
- Objectives stated by the manufacturer (these are not authorised claims)
- Joints
Declaration 175091, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Alpinia officinarum Hance | Racine | Extrait sec hydroalcoolique | 50 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Sulfate de glucosamine | not declared |
| Sulfate de chondroïtine | not declared |
Additives
E464, E460, E470b
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Déconseillé aux enfants et aux femmes enceintes et allaitantes. En cas de traitement anti-vitamine K, de diabète ou d’asthme, consulter un professionnel de santé avant la prise de ce produit.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “CHONDROÏTINE-GLUCOSAMINE LPEV®: composition and regulation”, https://compoatlas.com/en/supplements/products/175091-chondroitine-glucosamine-lpev, updated 15 November 2026.